Orthofix Director buys 50k shares in $1.63M transaction: 6 things to know

Orthofix Director Ronald A. Matricaria has bought a large number of the company’s stock in a transaction on June 2, according to a Sleek Money report.

Advertisement

Here are six things to know:

 

1. Mr. Matricaria bought 50,000 shares of the stock.

 

2. The stock was purchased at an average cost of $32.65 per share. The total value of the transaction is $1.63 million.

 

3. Following the transaction, Mr. Matricaria directly owns 66,000 shares in the company, valued at approximately $2.15 million.

 

4. Orthofix stock has a one-year low of $26.96 and a one-year high of $38.94.

 

5. The stock has a 50-day moving average of $34 and a 200-day moving average of $32.

 

6. The company’s market cap is $622.47 million.

 

More articles on devices:
Intelligent Implant Systems receives spine system patent — 5 things to know
Is the Zimmer-Biomet closed merger finally around the corner? 5 things to know
7 trends in the $850M bone graft substitute market

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.